Home
Altasciences

Altasciences Market Share Analysis for June 2026

contract research organization specialized in seamless, end-to-end, early phase drug development, we act to get your most promising compounds into and through early phase clinical trials.

Health > Biotechnology and Pharmaceuticals

Domainaltasciences.com

Year Founded1992

Employees1001 - 5000

Annual Revenue$100M - $200M

Altasciences

Altasciences (including company regionals)

altasciences.com

See more website traffic and engagement information

Altasciences Revenue up to June 2026 is 100M - 200M

revenue generated by Altasciences top domains

Altasciences top domains revenue over 3 years

Revenue for Altasciences top domains

altasciences.com100M - 200M

See more with Sales Intelligence

Total visits to Altasciences's top domains

Understand Altasciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

altasciences.com130.2K

See more with Sales Intelligence

Avg. visit duration in Altasciences's top domains

Analyze Altasciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

altasciences.com00:00:53

See more with Sales Intelligence

Avg. pageviews on Altasciences's top domains

See how Altasciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

altasciences.com2.12

See more with Sales Intelligence

Altasciences top competitors by domain

Top similar sites in June 2026, ranked by their affinity

syngeneintl.comCompany NameSyngeneEmployees5001 - 10000HQIndia, BangaloreAnnual revenue$200M - $500MTotal visits65.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Altasciences

These are the website technologies, by industry, used by Altasciences top domains

Advertising (27)

DoubleClick

Conversion & Analytics (11)

Google Analytics

Marketing (8)

Google Marketing Platform

Audio Video Media (5)

YouTube

More Technologies

14

See all

News & Signals from Altasciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAltasciences Co. partnered with Evidence Matters Inc. on Aug 1st '25.LAVAL, Québec - Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) of RegulatoryFlow ("RegFlow"), following the announcement of the companies' strategic collaboration in August 2025.

NewsAltasciences Co. partnered with Certara Inc. on May 7th '26.LAVAL, Québec, and Radnor, PA - May 7, 2026 - Altasciences, a fully integrated drug development solution company, and Certara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs.

NewsAltasciences Co. hired Chris Perkin as CEO on Jul 1st '10.Chris joined Altasciences as CEO in 2010 and has played a central role in transforming the company from a clinical research organization, focused on testing of generic drugs, into a fully integrated early-phase contract research and contract drug manufacturing organization operating across nine North American locations.